Cargando…
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
Disturbance of the gut microbiota is common in liver cirrhosis (LC) patients, the underlying mechanisms of which are yet to be unfolded. This study aims to explore the relationship between small bowel transit (SBT) and gut microbiota in LC patients. Cross-sectional design was applied with 36 LC pati...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946013/ https://www.ncbi.nlm.nih.gov/pubmed/29780327 http://dx.doi.org/10.3389/fphys.2018.00470 |
_version_ | 1783322105487556608 |
---|---|
author | Liu, Yang Jin, Ye Li, Jun Zhao, Lei Li, Zhengtian Xu, Jun Zhao, Fuya Feng, Jing Chen, Huinan Fang, Chengyuan Shilpakar, Rojina Wei, Yunwei |
author_facet | Liu, Yang Jin, Ye Li, Jun Zhao, Lei Li, Zhengtian Xu, Jun Zhao, Fuya Feng, Jing Chen, Huinan Fang, Chengyuan Shilpakar, Rojina Wei, Yunwei |
author_sort | Liu, Yang |
collection | PubMed |
description | Disturbance of the gut microbiota is common in liver cirrhosis (LC) patients, the underlying mechanisms of which are yet to be unfolded. This study aims to explore the relationship between small bowel transit (SBT) and gut microbiota in LC patients. Cross-sectional design was applied with 36 LC patients and 20 healthy controls (HCs). The gut microbiota was characterized by 16S rRNA gene sequencing. The Firmicutes/Bacteroidetes (F/B) ratio and the Microbial Dysbiosis index (MDI) were used to evaluate the severity of microbiota dysbiosis. The scintigraphy method was performed in patients to describe the objective values of SBT. Patients were then subdivided according to the Child–Pugh score (threshold = 5) or SBT value (threshold = 0.6) for microbiota analysis. LC patients were characterized by an altered gut microbiota; F/B ratios and MDI were higher than HC in both Child_5 (14.00 ± 14.69 vs. 2.86 ± 0.99, p < 0.01; 0.49 ± 0.80 vs. -0.47 ± 0.69, p < 0.01) and Child_5+ (15.81 ± 15.11 vs. 2.86±0.99, p < 0.01; 1.11 ± 1.05 vs. -0.47 ± 0.69, p < 0.01) sub-groups in patients. Difference in the gut microbiota between Child_ 5 and Child_5+ patients was inappreciable, but the SBT was relatively slower in Child_5+ patients (43 ± 26% vs. 80 ± 15%, p < 0.05). Compared with the Child–Pugh score indicators, SBT showed stronger associations with bacterial genera. A clear difference in the gut microbiota was observed between SBT_0.6- and SBT_0.6+ patients [Pr(>F) = 0.0068, pMANOVA], with higher F/B ratios and MDI in SBT_0.6- patients (19.71 ± 16.62 vs. 7.33 ± 6.65, p < 0.01; 1.02 ± 0.97 vs. 0.20 ± 0.58, p < 0.01). Similar results were observed between the SBT_0.6- and SBT_0.6+ sub-groups of patients with normal liver function and a Child–Pugh score of 5. SBT was negatively correlated with both the F/B ratio and MDI (r = -0.34, p < 0.05; r = -0.38, p < 0.05). Interestingly, an increased capacity for the inferred pathway “bacterial invasion of epithelial cells” in patients, was highly negatively correlated with SBT (r = -0.57, p < 0.01). The severity of microbiota dysbiosis in LC patients depends on SBT rather than Child–Pugh score. SBT per se might be significantly related to the gut microbiota abnormalities observed in patients with LC. |
format | Online Article Text |
id | pubmed-5946013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59460132018-05-18 Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis Liu, Yang Jin, Ye Li, Jun Zhao, Lei Li, Zhengtian Xu, Jun Zhao, Fuya Feng, Jing Chen, Huinan Fang, Chengyuan Shilpakar, Rojina Wei, Yunwei Front Physiol Physiology Disturbance of the gut microbiota is common in liver cirrhosis (LC) patients, the underlying mechanisms of which are yet to be unfolded. This study aims to explore the relationship between small bowel transit (SBT) and gut microbiota in LC patients. Cross-sectional design was applied with 36 LC patients and 20 healthy controls (HCs). The gut microbiota was characterized by 16S rRNA gene sequencing. The Firmicutes/Bacteroidetes (F/B) ratio and the Microbial Dysbiosis index (MDI) were used to evaluate the severity of microbiota dysbiosis. The scintigraphy method was performed in patients to describe the objective values of SBT. Patients were then subdivided according to the Child–Pugh score (threshold = 5) or SBT value (threshold = 0.6) for microbiota analysis. LC patients were characterized by an altered gut microbiota; F/B ratios and MDI were higher than HC in both Child_5 (14.00 ± 14.69 vs. 2.86 ± 0.99, p < 0.01; 0.49 ± 0.80 vs. -0.47 ± 0.69, p < 0.01) and Child_5+ (15.81 ± 15.11 vs. 2.86±0.99, p < 0.01; 1.11 ± 1.05 vs. -0.47 ± 0.69, p < 0.01) sub-groups in patients. Difference in the gut microbiota between Child_ 5 and Child_5+ patients was inappreciable, but the SBT was relatively slower in Child_5+ patients (43 ± 26% vs. 80 ± 15%, p < 0.05). Compared with the Child–Pugh score indicators, SBT showed stronger associations with bacterial genera. A clear difference in the gut microbiota was observed between SBT_0.6- and SBT_0.6+ patients [Pr(>F) = 0.0068, pMANOVA], with higher F/B ratios and MDI in SBT_0.6- patients (19.71 ± 16.62 vs. 7.33 ± 6.65, p < 0.01; 1.02 ± 0.97 vs. 0.20 ± 0.58, p < 0.01). Similar results were observed between the SBT_0.6- and SBT_0.6+ sub-groups of patients with normal liver function and a Child–Pugh score of 5. SBT was negatively correlated with both the F/B ratio and MDI (r = -0.34, p < 0.05; r = -0.38, p < 0.05). Interestingly, an increased capacity for the inferred pathway “bacterial invasion of epithelial cells” in patients, was highly negatively correlated with SBT (r = -0.57, p < 0.01). The severity of microbiota dysbiosis in LC patients depends on SBT rather than Child–Pugh score. SBT per se might be significantly related to the gut microbiota abnormalities observed in patients with LC. Frontiers Media S.A. 2018-05-01 /pmc/articles/PMC5946013/ /pubmed/29780327 http://dx.doi.org/10.3389/fphys.2018.00470 Text en Copyright © 2018 Liu, Jin, Li, Zhao, Li, Xu, Zhao, Feng, Chen, Fang, Shilpakar and Wei. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Liu, Yang Jin, Ye Li, Jun Zhao, Lei Li, Zhengtian Xu, Jun Zhao, Fuya Feng, Jing Chen, Huinan Fang, Chengyuan Shilpakar, Rojina Wei, Yunwei Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis |
title | Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis |
title_full | Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis |
title_fullStr | Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis |
title_full_unstemmed | Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis |
title_short | Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis |
title_sort | small bowel transit and altered gut microbiota in patients with liver cirrhosis |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946013/ https://www.ncbi.nlm.nih.gov/pubmed/29780327 http://dx.doi.org/10.3389/fphys.2018.00470 |
work_keys_str_mv | AT liuyang smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT jinye smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT lijun smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT zhaolei smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT lizhengtian smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT xujun smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT zhaofuya smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT fengjing smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT chenhuinan smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT fangchengyuan smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT shilpakarrojina smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis AT weiyunwei smallboweltransitandalteredgutmicrobiotainpatientswithlivercirrhosis |